Abstract
Objective: The aim of this pilot study was to analyze the first results after implantation of the metabolic study as recommended by the care process Integrated Urolitiasis of the Ministry of Health of the Government of Andalusia in our health area. Material and Methods: Prospective pilot study including a cohort of 16 patients in whom a metabolic study is performed to present multiple/recurrent stones after implantation of protocol, a posterior to a SWOT analysis. Cost metabolic study, results of metabolic study and implementation of individualized treatment is analyzed. Besides the direct / indirect costs of urolithiasis and the need and indication of metabolic study and compliance indicator of quality are analyzed. Results: Of the 16 patients that the study was conducted, it appears that the prescription studied metabolic study in patients with nephrolithiasis risk indicator is fulfilled in 100%. One or more alterations in 75% of patients is detected, leading to a single medical treatment guidelines that facilitate reducing recurrence and economic saving direct/indirect costs arising from the stones. The average cost of metabolic study per patient is 37.7 euros. Conclusion: The development of a protocol, previous a situation analysis, together with the application of a metabolic study and individual treatment is a measure of health quality in patients with nephrolithiasis presumably favor the reduction of recurrence and costs.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call